The European Commission has recently published a comprehensive package of regulatory reforms for the pharmaceutical sector in the European Union (EU), setting out a legislative action plan and strategic vision that seeks to balance greater patient access, improved regulatory efficiency, and the need to boost the Life Sciences sector’s global competitiveness. Join us, Tim Wilsdon and Anthony Barron, as we explore some of the key components of the new Pharmaceutical Strategy for Europe and set out some of the policy initiatives stemming from the strategy.
Ken Beers joins CRA's Life Sciences Practice as Vice President
CRA is proud to welcome Kenneth J. Beers as a vice president in the Life Sciences Practice. Mr. Beers supports biopharmaceutical clients across a range of...